A detailed history of Readystate Asset Management LP transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Readystate Asset Management LP holds 5,482 shares of REGN stock, worth $4.08 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
5,482
Previous 400 1270.5%
Holding current value
$4.08 Million
Previous $420 Million 1270.77%
% of portfolio
0.11%
Previous 0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1024.09 - $1201.76 $5.61 Million - $6.59 Million
5,482 New
5,482 $5.76 Billion

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $79.8B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Readystate Asset Management LP Portfolio

Follow Readystate Asset Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Readystate Asset Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Readystate Asset Management LP with notifications on news.